The Latest Analyst Ratings For Bicycle Therapeutics
The Latest Analyst Ratings For Bicycle Therapeutics
Bicycle Therapeutics的最新分析師評級
In examining recent analyst actions, we gain insights...Ratings for Bicycle Therapeutics (NASDAQ:BCYC) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，共有4位分析師爲Bicycle Therapeutics（NASDAQ:BCYC）評級，呈現出看好和看淡的觀點混合。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖，顯示了過去30天的不同情緒，並將其與前幾個月進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $42.25, a high estimate of $55.00, and a low estimate of $28.00. This current average has decreased by 2.87% from the previous average price target of $43.50.
分析師分析了12個月的價位目標，平均目標爲42.25美元，最高目標爲55.00美元，最低目標爲28.00美元。這個平均值比先前的平均價格目標43.50美元下降了2.87%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
In examining recent analyst actions, we gain insights...
通過研究近期的分...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間